SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPollen Street Regulatory News (POLN)

Share Price Information for Pollen Street (POLN)

Share Price is delayed by 15 minutes
Get Live Data
867.00    15.00 (1.76%)
Bid:
867.00
Ask:
873.00
Spread: 6.00 (0.692%)
Market Cap: £515.62m
POLN Live PriceLast checked at - London Stock Exchange

Intraday Pollen Street Share Chart

Directorate changes

30 Jan 2026 10:59

RNS Number : 1189R
Pollen Street Group Limited
30 January 2026
 

30 January 2026

Pollen Street Group Limited

("Pollen Street" or the "Company")

Directorate Changes

 

The Company announces the following changes to its Board of Directors.

Appointment of Independent Non-Executive Director

The Company confirms the appointment of Robert Ohrenstein as an independent Non-Executive Director, effective from 29 January, 2026. Upon joining the Board, Mr Ohrenstein will also become a member of the Audit and Risk Committees.

Retirement of Senior Independent Director and Audit Committee Chair

As previously disclosed, Jim Coyle, Senior Independent Director and Chair of the Audit Committee, will retire from the Board at the Annual General Meeting to be held in April 2026 following the completion of his nine-year tenure.

Committee and Board Role Transitions

Following Mr Coyle's retirement, Mr Ohrenstein will be appointed Chair of the Audit Committee with effect from 1 May 2026. In addition, Richard Rowney (Independent Non-Executive Director and Risk Committee Chair) will be appointed as Senior Independent Director from 1 May 2026.

About Robert Ohrenstein

Mr Ohrenstein brings extensive private equity and financial knowledge with over three decades of experience in financial and professional services. Mr Ohrenstein was Global Head of Private Equity at KPMG for almost ten years, and most recently was a UK Vice Chair. At KPMG, he set the firm's global private equity strategy including formulating and implementing a major global investment plan for the firm. Mr Ohrenstein holds an MBA from the University of Warwick and a BSc (Econ) from the London School of Economics. He is a Fellow of the Institute of Chartered Accountants in England and Wales. He currently serves as Non-Executive Director and Audit Committee Chair of PTSG Group Ltd, is an Operations Adviser for Advent International, and acts as senior adviser to a number of Private Equity firms.

Lynn Fordham, Chair of Pollen Street, said: "Jim has made an exceptional contribution to the Board over the course of his tenure and I would like to thank him for his commitment and leadership, particularly in his role as Chair of the Audit Committee.

We are pleased to welcome Robert to the Board. His depth of experience and financial expertise will be a valuable addition as the Company continues to execute its strategy and maintain high standards of governance."

Lindsey McMurray, CEO of Pollen Street, added: "I would like to thank Jim for his hard work and valuable support during his years on the Board. We are pleased to welcome Robert and look forward to the experience and perspective he brings as we continue to build the business."

Robert Ohrenstein commented: "Pollen Street has established a strong platform and a clear strategic focus. I am excited to be taking on this role and look forward to working with the Board and management team to help drive the Company's continued growth and, in my role as Chair of the Audit Committee, to supporting its high governance standards as the business develops."

The Company makes this announcement in accordance with LR 6.4.8 of the UK Listing Rules. There are no other matters to be disclosed under LR 6.4.8.

About Pollen Street

Pollen Street is an alternative asset manager dedicated to investing within the financial and business services sectors across both Private Equity and Private Credit strategies. Founded in 2013, the Group has consistently delivered top-tier returns alongside growing AuM.

Pollen Street operates through two complementary segments: the Asset Manager, which manages third-party AuM, and the Investment Company, which invests on balance sheet to generate attractive returns and accelerate AuM growth through alignment with investors.

POLN is listed on the London Stock Exchange (ticker symbol: POLN) and is a member of the FTSE 250 index. Further details are available at www.pollenstreetgroup.com

 

For further information about this announcement please contact:

 

Pollen Street - Corporate Development Director

Shweta Chugh

+44 (0)20 3965 5081

 

Barclays Bank plc - Joint Broker

Neal West / Stuart Muress

+44 (0)20 7623 2323

 

Investec Bank plc - Joint Broker

Ben Griffiths / Kamalini Hull

+44 (0)20 7597 4000

 

FGS Global

Chris Sibbald / Anna Tabor

PollenStreetCapital-LON@fgsglobal.com

 

MUFG Corporate Governance Limited

Company Secretary

POLNcosec@cm.mpms.mufg.com

 

LEI 894500LP94M98N8CY487 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAWPUMAGUPQGUU
Date   Source Headline
4th Oct 20247:00 amRNSTransaction in Own Shares
1st Oct 20242:06 pmRNSTotal Voting Rights
27th Sep 20247:00 amRNSTransaction in Own Shares
25th Sep 20247:00 amRNSTransaction in Own Shares
19th Sep 20244:33 pmRNSInvestor Presentation via Investor Meet Company
19th Sep 20247:00 amRNSTransaction in Own Shares
5th Sep 20243:33 pmRNSInterim Dividend Declaration
5th Sep 20247:00 amRNSTransaction in Own Shares
4th Sep 20247:00 amRNSInterim Accounts H1 2024
2nd Sep 20243:19 pmRNSReplacement: Total Voting Rights
2nd Sep 202412:10 pmRNSTotal Voting Rights
29th Aug 20247:00 amRNSTransaction in Own Shares
16th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20247:00 amRNSTransaction in Own Shares
1st Aug 20249:37 amRNSTotal Voting Rights
11th Jul 20247:00 amRNSTransaction in Own Shares
5th Jul 20247:00 amRNSTransaction in Own Shares
2nd Jul 20247:00 amRNSTransaction in Own Shares
1st Jul 20243:09 pmRNSTotal Voting Rights
27th Jun 20247:00 amRNSTransaction in Own Shares
26th Jun 20247:00 amRNSTransaction in Own Shares
25th Jun 20244:52 pmRNSHolding(s) in Company
25th Jun 20247:00 amRNSTransaction in Own Shares
24th Jun 20247:00 amRNSTransaction in Own Shares
21st Jun 20247:00 amRNSTransaction in Own Shares
20th Jun 20247:00 amRNSTransaction in Own Shares
17th Jun 20244:18 pmRNSHolding(s) in Company
14th Jun 20243:00 pmRNSResult of AGM
14th Jun 20242:42 pmRNSHolding(s) in Company
14th Jun 20247:00 amRNSTransaction in Own Shares
12th Jun 20247:00 amRNSTransaction in Own Shares
11th Jun 20247:00 amRNSTransaction in Own Shares
3rd Jun 20244:25 pmRNSTotal Voting Rights
21st May 20247:00 amRNSPosting of Notice of AGM
10th May 20247:00 amRNSTransaction in Own Shares
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20245:21 pmRNSDirector/PDMR Shareholding
3rd May 20247:00 amRNSTrading Statement
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20243:46 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSAnnual Financial Report
29th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 202411:34 amRNSInvestor Presentation via Investor Meet Company
5th Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20245:12 pmRNSDirector/PDMR Shareholding
25th Mar 20245:00 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSAnnual Report and Accounts
21st Mar 20247:00 amRNSShare Buyback Programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.